Pubblicazioni

Autori:

Rossini, Maurizio; Viapiana, Ombretta; Zanotti, Roberta; Tripi, Gaia; Perbellini, Omar; Idolazzi, Luca; Bonifacio, Massimiliano; Adami, Silvano; Gatti, Davide

Titolo:

Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis

Anno:

2015

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Formato:

A Stampa

Referee:

No

Nome rivista:

Calcified Tissue International

ISSN Rivista:

0171-967X

N° Volume:

96

Numero o Fascicolo:

5

Intervallo pagine:

410-416

Parole chiave:

mastocytosis, osteoporosis, DKK1, sclerostin

Breve descrizione dei contenuti:

Bone involvement, mainly osteoporosis but also osteosclerosis, is frequent in patients with indolent systemic mastocytosis (ISM). The recent characterization of the canonical Wnt/β-catenin pathway in the regulation of bone remodeling provided important insights for our understanding of the pathophysiology of a number of conditions. The regulation of Wnt pathway in bone is predominantly driven by the production of receptor inhibitors such as Dickkopf-1 (DKK1) and sclerostin (SOST). This study aimed to explore if the various bone involvements in patients with ISM might be explained by variations in serum levels of DKK1 and SOST. This is a cross-sectional study in an adult ISM cohort (13 men and 13 women with diagnosed ISM) and fifty-two healthy sex and age-matched controls. Early morning, fasting and venous sampling was obtained in all subjects. The main outcome measures were serum bone-specific alkaline phosphatase (bALP), C-terminal telopeptides of type I collagene (CTX), DKK1, SOST, parathyroid hormone (PTH), bone mineral density, and prevalent vertebral fractures. Mean DKK1 serum levels were about two-folds higher in patients, than in controls (65,0 ± 43.3 vs. 33.1 ± 19.4 pmol/L, respectively; p < 0.001), irrespective of the presence of osteoporotic or diffuse osteosclerotic bone involvement. DKK1 serum levels were positively correlated with PTH and both CTX and bALP. Mean SOST serum levels were not significantly different in patients versus controls, and we did not observe any significant correlation between SOST and any available clinical or laboratory parameters, with the only exception of a positive correlation with age. In conclusion, in our study, we observed that DKK1, but not SOST, serum levels significantly increased in ISM patients with various bone involvements, and correlated with PTH and bone turnover markers. Our results suggest that the Wnt/β-catenin pathway is not primarily involved in the pathophysiology of the array of bone involvement in ISM.

Id prodotto:

89377

Handle IRIS:

11562/930455

ultima modifica:

15 novembre 2022

Citazione bibliografica:

Rossini, Maurizio; Viapiana, Ombretta; Zanotti, Roberta; Tripi, Gaia; Perbellini, Omar; Idolazzi, Luca; Bonifacio, Massimiliano; Adami, Silvano; Gatti, Davide, Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis «Calcified Tissue International» , vol. 96 , n. 5 , 2015 , pp. 410-416

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo